These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26439773)

  • 41. Automated gleason grading on prostate biopsy slides by statistical representations of homology profile.
    Yan C; Nakane K; Wang X; Fu Y; Lu H; Fan X; Feldman MD; Madabhushi A; Xu J
    Comput Methods Programs Biomed; 2020 Oct; 194():105528. PubMed ID: 32470903
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Stratification of Contemporary Patients Undergoing Radical Prostatectomy for High-risk Prostate Cancer.
    Jo JK; Kook HR; Byun SS; Lee SE; Hong SK
    Ann Surg Oncol; 2015; 22(6):2088-93. PubMed ID: 25398277
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Brief Overview of Prostate Cancer Statistics, Grading, Diagnosis and Treatment Strategies.
    Schatten H
    Adv Exp Med Biol; 2018; 1095():1-14. PubMed ID: 30229546
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An update of the Gleason grading system.
    Epstein JI
    J Urol; 2010 Feb; 183(2):433-40. PubMed ID: 20006878
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lack of association of prostate carcinoma nuclear grading with prostate specific antigen recurrence after radical prostatectomy.
    Zhou M; Hayasaka S; Taylor JM; Shah R; Proverbs-Singh T; Manley S; Rubin MA
    J Urol; 2001 Dec; 166(6):2193-7. PubMed ID: 11696734
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Application of Gleason analogous grading system and flow cytometry DNA analysis in a novel knock-in mouse prostate cancer model.
    Wu G; Yu L; Wang L; Wang H; Xuan JW
    Postgrad Med J; 2006 Jan; 82(963):40-5. PubMed ID: 16397079
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Similarities and Differences in the 2019 ISUP and GUPS Recommendations on Prostate Cancer Grading: A Guide for Practicing Pathologists.
    Smith SC; Gandhi JS; Moch H; Aron M; Compérat E; Paner GP; McKenney JK; Amin MB
    Adv Anat Pathol; 2021 Jan; 28(1):1-7. PubMed ID: 33027069
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adenocarcinoma of the prostate with Gleason pattern 5 on core biopsy: frequency of diagnosis, morphologic subpatterns, and relation to pattern distribution based on the modified Gleason grading system.
    Shah RB; Tadros Y
    Hum Pathol; 2014 Nov; 45(11):2263-9. PubMed ID: 25228336
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prostate-specific antigen vs prostate-specific antigen density as a predictor of upgrading in men diagnosed with Gleason 6 prostate cancer by contemporary multicore prostate biopsy.
    Oh JJ; Hong SK; Lee JK; Lee BK; Lee S; Kwon OS; Byun SS; Lee SE
    BJU Int; 2012 Dec; 110(11 Pt B):E494-9. PubMed ID: 22540236
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prostate Cancer Grading: A Contemporary Photomontage.
    Epstein JI
    Am J Surg Pathol; 2016 Jan; 40(1):137. PubMed ID: 26658665
    [No Abstract]   [Full Text] [Related]  

  • 51. A concise update on prostate pathology.
    Xu W; Zhou M
    Cesk Patol; 2014; 50(4):120-8. PubMed ID: 25418898
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Grading of prostatic adenocarcinoma: current state and prognostic implications.
    Gordetsky J; Epstein J
    Diagn Pathol; 2016 Mar; 11():25. PubMed ID: 26956509
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Grading of prostate cancer].
    Kristiansen G; Roth W; Helpap B
    Pathologe; 2016 Jul; 37(4):352-4. PubMed ID: 27393141
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Practice patterns related to prostate cancer grading: results of a 2019 Genitourinary Pathology Society clinician survey.
    Fine SW; Trpkov K; Amin MB; Algaba F; Aron M; Baydar DE; Beltran AL; Brimo F; Cheville JC; Colecchia M; Comperat E; Costello T; da Cunha IW; Delprado W; DeMarzo AM; Giannico GA; Gordetsky JB; Guo CC; Hansel DE; Hirsch MS; Huang J; Humphrey PA; Jimenez RE; Khani F; Kong MX; Kryvenko ON; Kunju LP; Lal P; Latour M; Lotan T; Maclean F; Magi-Galluzzi C; Mehra R; Menon S; Miyamoto H; Montironi R; Netto GJ; Nguyen JK; Osunkoya AO; Parwani A; Pavlovich CP; Robinson BD; Rubin MA; Shah RB; So JS; Takahashi H; Tavora F; Tretiakova MS; True L; Wobker SE; Yang XJ; Zhou M; Zynger DL; Epstein JI
    Urol Oncol; 2021 May; 39(5):295.e1-295.e8. PubMed ID: 32948433
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The updated grading system of prostate carcinoma: an inter-observer agreement study among general pathologists in an academic practice.
    Al Nemer AM; Elsharkawy T; Elshawarby M; Al-Tamimi D; Kussaibi H; Ahmed A
    APMIS; 2017 Nov; 125(11):957-961. PubMed ID: 28913842
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical Utility of Quantitative Gleason Grading in Prostate Biopsies and Prostatectomy Specimens.
    Sauter G; Steurer S; Clauditz TS; Krech T; Wittmer C; Lutz F; Lennartz M; Janssen T; Hakimi N; Simon R; von Petersdorff-Campen M; Jacobsen F; von Loga K; Wilczak W; Minner S; Tsourlakis MC; Chirico V; Haese A; Heinzer H; Beyer B; Graefen M; Michl U; Salomon G; Steuber T; Budäus LH; Hekeler E; Malsy-Mink J; Kutzera S; Fraune C; Göbel C; Huland H; Schlomm T
    Eur Urol; 2016 Apr; 69(4):592-598. PubMed ID: 26542947
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Web-grading-a tool to test personal grading of renal and prostate cancer.
    Kristiansen G; Schmid M; Egevad L; Samaratunga H; Varma M; Inam K; Thiesen HJ; Delahunt B; Dai Y
    APMIS; 2023 Oct; 131(10):528-535. PubMed ID: 37620988
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The evolving Gleason grading system.
    Chen N; Zhou Q
    Chin J Cancer Res; 2016 Feb; 28(1):58-64. PubMed ID: 27041927
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pathologic prostate cancer characteristics in patients eligible for active surveillance: a head-to-head comparison of contemporary protocols.
    Iremashvili V; Pelaez L; Manoharan M; Jorda M; Rosenberg DL; Soloway MS
    Eur Urol; 2012 Sep; 62(3):462-8. PubMed ID: 22445138
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic Value of the New Prostate Cancer International Society of Urological Pathology Grade Groups.
    Offermann A; Hohensteiner S; Kuempers C; Ribbat-Idel J; Schneider F; Becker F; Hupe MC; Duensing S; Merseburger AS; Kirfel J; Reischl M; Lubczyk V; Kuefer R; Perner S
    Front Med (Lausanne); 2017; 4():157. PubMed ID: 29034236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.